Vial

INDIVIDUAL TEST 926

C1 INH Function

Indication

Suspicion of angioedema

Sample material

EDTA-plasma

  • Minim. volume: 0,5 mL

Transport

  • Within Sweden: frozen
  • International: frozen

Method

Spectrophotometry

Reference interval

72-129%

Result

The result is reported as normal or low as a percentage of normal human serum.

Interpretation

Results below the lower reference limit may indicate hereditary angioedema (HAE) type 1 or consumption of C1-inhibitor (can be seen in some malignancies). The result should primarily be verified with a new sample as well as to include analysis of the concentrations of C1-inhibitor and C4.

References

  • Li HH et al. Allergy Asthma Clin Immunol. 2019. Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. PMID: 31485239
  • Maurer M et al. World Allergy Organ J. 2022. The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. PMID: 35497649

Last updated: 2025-12-05

More information

Learn more about sampling.
> Read more

Download request forms

Autoimmune diagnostics

Can't find what you're looking for? We are here to help

Vial

ENSKILD ANALYS 926

C1-INH funktion

Indikation

Misstanke om angioödem

Provmaterial

EDTA-plasma

  • Minim. volym: 0,5 mL

Transport

  • Inom Sverige: fryst
  • Internationellt: fryst

Metod

Spektrofotometri

Referensintervall

72-129%

Resultat

Resultatet anges som normal eller sänkt med procent av normalt humanserum.

Tolkning

Resultat under nedre referensgränsen kan tyda på hereditärt angioödem (HAE) typ 1 eller konsumtion av C1-inhibitor (kan ses vid vissa maligniteter). Resultatet bör i första hand verifieras med nytt prov för verifiering och även inkludera analys av koncentration av C1-inhibitor och C4.

Referenser

  • Li HH et al. Allergy Asthma Clin Immunol. 2019. Subcutaneous C1 inhibitor for prevention of attacks of hereditary angioedema: additional outcomes and subgroup analysis of a placebo-controlled randomized study. PMID: 31485239
  • Maurer M et al. World Allergy Organ J. 2022. The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. PMID: 35497649

Senast uppdaterat: 2025-12-05

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Autoimmun diagnostik

Hittar du inte vad du söker? Vi kan hjälpa till